|
Delaware
(State or other jurisdiction of
Incorporation or Organization) |
| |
7374
(Primary Standard Industrial
Classification Code Number) |
| |
87-1909475
(I.R.S. Employer
Identification Number) |
|
|
W. Morgan Burns
Joshua L. Colburn W. Jason Deppen Faegre Drinker Biddle & Reath LLP 90 South Seventh Street 2200 Wells Fargo Center Minneapolis, Minnesota 55402 (612) 766-7000 |
| |
Paul Prager
Chief Executive Officer TeraWulf Inc. 9 Federal Street Easton, Maryland 21601 (410) 770-9500 |
| |
Ariel J. Deckelbaum
Sarah Stasny David S. Huntington Paul, Weiss, Rifkind, Wharton & Garrison LLP 1285 Avenue of the Americas New York, New York 10019 (212) 373-3000 |
|
|
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
| | | |
Emerging growth company
☐
|
|
| | ||||||||||||||||||||||||||||
Title of each class of securities to be registered
|
| | |
Amount to be
registered |
| | |
Proposed maximum
offering price per share |
| | |
Proposed maximum
aggregate offering price |
| | |
Amount of
registration fee |
| ||||||||||||
Common Stock, par value $0.001 per share
|
| | | | | 104,550,200(a) | | | | | | | N/A | | | | | | $ | 109,553,842(b) | | | | | | $ | 11,952.33 | | |
| | |
Page
|
| |||
| | | | 4 | | | |
| | | | 10 | | | |
| | | | 12 | | | |
| | | | 23 | | | |
| | | | 24 | | | |
| | | | 34 | | | |
| | | | 35 | | | |
| | | | 58 | | | |
| | | | 59 | | | |
| | | | 90 | | | |
| | | | 95 | | | |
| | | | 107 | | | |
| | | | 108 | | | |
| | | | 122 | | | |
| | | | 126 | | | |
| | | | 130 | | | |
| | | | 138 | | | |
| | | | 144 | | | |
| | | | 152 | | | |
| | | | 154 | | | |
| | | | 155 | | | |
| | | | 156 | | | |
| | | | 159 | | | |
| | | | 160 | | | |
| | | | 161 | | | |
| | | | 163 | | | |
| | | | 165 | | | |
| | | | 168 | | | |
| | | | 174 | | | |
| | | | 176 | | | |
| | | | 177 | | | |
| | | | 177 | | | |
| | | | 177 | | |
| | | | | A-1 | | | |
| | | | | B-1 | | | |
| | | | | C-1 | | | |
| | | | | D-1 | | | |
| | | | | E-1 | | | |
| | | | | F-1 | | | |
| | | | | G-1 | | | |
| | | | | H-1 | | |
| | |
(1)TeraWulf
|
| |
(2)IKONICS
|
| |
Pro Forma
Adjustments |
| |
Note 3
|
| |
Pro Forma
Combined |
| |||||||||||||||
ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CURRENT ASSETS: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash
|
| | | $ | 6,300,000 | | | | | $ | 4,428,269 | | | | | $ | (10,407,990) | | | | | | (c) | | | | | $ | 320,279 | | |
Trade receivables, net
|
| | | | — | | | | | | 1,545,527 | | | | | | — | | | | | | | | | | | | 1,545,527 | | |
Inventories
|
| | | | — | | | | | | 1,961,916 | | | | | | — | | | | | | | | | | | | 1,961,916 | | |
Prepaid expenses and other assets
|
| | | | 5,000 | | | | | | 228,644 | | | | | | — | | | | | | | | | | | | 233,644 | | |
Total current assets
|
| | | | 6,305,000 | | | | | | 8,164,356 | | | | | | (10,407,990) | | | | | | | | | | | | 4,061,366 | | |
PROPERTY, PLANT, AND EQUIPMENT: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Property, plant and equipment
|
| | | | — | | | | | | 16,483,065 | | | | | | (9,255,263) | | | | | | (f) | | | | | | 7,227,802 | | |
Less accumulated depreciation
|
| | | | — | | | | | | (9,255,263) | | | | | | 9,225,263 | | | | | | (f) | | | | | | — | | |
Total property, plant and equipment at cost, net
|
| | | | — | | | | | | 7,227,802 | | | | | | — | | | | | | | | | | | | 7,227,802 | | |
Deposits
|
| | | | 23,700,000 | | | | | | — | | | | | | — | | | | | | | | | | | | 23,700,000 | | |
Intangible Assets, net
|
| | | | — | | | | | | 243,819 | | | | | | (243,819) | | | | | | (f) | | | | | | — | | |
Goodwill and acquired intangible assets
|
| | | | — | | | | | | — | | | | | | 62,917,908 | | | | | | (b) | | | | | | 62,917,908 | | |
Total assets
|
| | | $ | 30,005,000 | | | | | $ | 15,635,977 | | | | | $ | 52,266,099 | | | | | | | | | | | $ | 97,907,076 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CURRENT LIABILITIES: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current portion of long – term debt
|
| | | $ | — | | | | | $ | 2,654,019 | | | | | $ | — | | | | | | | | | | | $ | 2,654,019 | | |
Accounts payable and other accrued liabilities
|
| | | | 1,739,000 | | | | | | 1,420,373 | | | | | | 17,000,000 | | | | | | (e) | | | | | | 20,159,373 | | |
Contingent Value Rights
|
| | | | — | | | | | | — | | | | | | 10,142,967 | | | | | | (c) | | | | | | 10,142,967 | | |
Total current liabilities
|
| | | | 1,739,000 | | | | | | 4,074,392 | | | | | | 27,142,967 | | | | | | | | | | | | 32,956,359 | | |
COMMITMENTS AND CONTINGENCIES | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock, par value $0.001 per share
|
| | | | 50,000 | | | | | | — | | | | | | 2,082 | | | | | | (c) | | | | | | 104,691 | | |
| | | | | | | | | | | | | | | | | 51,998 | | | | | | (d) | | | | | | | | |
| | | | | | | | | | | | | | | | | 611 | | | | | | (g) | | | | | | | | |
Common stock, par value $0.10 per share
|
| | | | — | | | | | | 197,710 | | | | | | (197,710) | | | | | | (a) | | | | | | — | | |
Additional paid-in-capital
|
| | | | 29,892,000 | | | | | | 2,787,733 | | | | | | (2,787,733) | | | | | | (a) | | | | | | 96,022,026 | | |
| | | | | | | | | | | | | | | | | 53,682,635 | | | | | | (c) | | | | | | | | |
| | | | | | | | | | | | | | | | | (51,998) | | | | | | (d) | | | | | | | | |
| | | | | | | | | | | | | | | | | 12,499,389 | | | | | | (g) | | | | | | | | |
Retained earnings / (accumulated deficit)
|
| | | | (1,676,000) | | | | | | 8,576,142 | | | | | | (8,576,142) | | | | | | (a) | | | | | | (31,176,000) | | |
| | | | | | | | | | | | | | | | | (17,000,000) | | | | | | (e) | | | | | | | | |
| | | | | | | | | | | | | | | | | (12,500,000) | | | | | | (g) | | | | | | | | |
Total stockholders’ equity
|
| | | | 28,266,000 | | | | | | 11,561,585 | | | | | | 25,123,132 | | | | | | | | | | | | 64,950,717 | | |
Total liabilities and stockholders’ equity
|
| | | $ | 30,005,000 | | | | | $ | 15,635,977 | | | | | $ | 52,266,099 | | | | | | | | | | | $ | 97,907,076 | | |
| | |
(1)TeraWulf
|
| |
(2)IKONICS
|
| |
Pro Forma
Adjustments |
| |
Note 3
|
| |
Pro Forma
Combined |
| |||||||||||||||
Net sales
|
| | | $ | — | | | | | $ | 3,073,408 | | | | | $ | — | | | | | | | | | | | $ | 3,073,408 | | |
Cost of goods sold
|
| | | | — | | | | | | 2,077,076 | | | | | | — | | | | | | | | | | | | 2,077,076 | | |
Gross profit
|
| | | | — | | | | | | 996,332 | | | | | | — | | | | | | | | | | | | 996,332 | | |
Cost of operations: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Operating expenses
|
| | | | 853,000 | | | | | | — | | | | | | — | | | | | | | | | | | | 853,000 | | |
Selling, general and administrative expenses
|
| | | | 823,000 | | | | | | 1,183,591 | | | | | | — | | | | | | | | | | | | 2,006,591 | | |
Research and development
expenses |
| | | | — | | | | | | 134,922 | | | | | | — | | | | | | | | | | | | 134,922 | | |
Total cost of operations
|
| | | | 1,676,000 | | | | | | 1,318,513 | | | | | | — | | | | | | | | | | | | 2,994,513 | | |
Loss from operations
|
| | | | (1,676,000) | | | | | | (322,181) | | | | | | — | | | | | | | | | | | | (1,998,181) | | |
Interest expense
|
| | | | — | | | | | | (19,842) | | | | | | — | | | | | | | | | | | | (19,842) | | |
Other income
|
| | | | — | | | | | | 37 | | | | | | — | | | | | | | | | | | | 37 | | |
Loss before income taxes
|
| | | | (1,676,000) | | | | | | (341,986) | | | | | | — | | | | | | | | | | | | (2,017,986) | | |
Income tax benefit
|
| | | | — | | | | | | (20,347) | | | | | | — | | | | | | | | | | | | (20,347) | | |
Net loss
|
| | | $ | (1,676,000) | | | | | $ | (321,639) | | | | | $ | — | | | | | | | | | | | $ | (1,997,639) | | |
Loss per common share: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted
|
| | | | | | | | | $ | (0.16) | | | | | | | | | | | | | | | | | $ | (0.02) | | |
Weighted average common shares outstanding:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted
|
| | | | | | | | | | 1,976,354 | | | | | | 102,714,376 | | | | | | (h) | | | | | | 104,691,147 | | |
| | |
(1)TeraWulf
|
| |
(2)IKONICS
|
| |
Pro Forma
Adjustments |
| |
Note 3
|
| |
Pro Forma
Combined |
| |||||||||||||||
Net sales
|
| | | $ | — | | | | | $ | 13,432,220 | | | | | $ | — | | | | | | | | | | | $ | 13,432,220 | | |
Cost of goods sold
|
| | | | — | | | | | | 9,527,143 | | | | | | — | | | | | | | | | | | | 9,527,143 | | |
Gross profit
|
| | | | — | | | | | | 3,905,077 | | | | | | — | | | | | | | | | | | | 3,905,077 | | |
Cost of operations: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Selling, general and administrative expenses
|
| | | | — | | | | | | 5,019,604 | | | | | | 12,500,000 | | | | | | (g) | | | | | | 17,519,604 | | |
Research and development expenses
|
| | | | — | | | | | | 671,493 | | | | | | — | | | | | | | | | | | | 671,493 | | |
Total cost of operations
|
| | | | — | | | | | | 5,691,097 | | | | | | 12,500,000 | | | | | | | | | | | | 18,191,097 | | |
Loss from operations
|
| | | | — | | | | | | (1,786,020) | | | | | | (12,500,000) | | | | | | | | | | | | (14,286,020) | | |
Interest expense
|
| | | | — | | | | | | (86,561) | | | | | | — | | | | | | | | | | | | (86,561) | | |
Other income
|
| | | | — | | | | | | 1,223,261 | | | | | | — | | | | | | | | | | | | 1,223,261 | | |
Loss before income taxes
|
| | | | — | | | | | | (649,320) | | | | | | (12,500,000) | | | | | | | | | | | | (13,149,320) | | |
Income tax benefit
|
| | | | — | | | | | | (210,000) | | | | | | — | | | | | | | | | | | | (210,000) | | |
Net loss
|
| | | $ | — | | | | | $ | (439,320) | | | | | $ | (12,500,000) | | | | | | | | | | | $ | (12,939,320) | | |
Loss per common share: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted
|
| | | | | | | | | $ | (0.22) | | | | | | | | | | | | | | | | | $ | (0.12) | | |
Weighted average common shares outstanding:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted
|
| | | | | | | | | | 1,976,771 | | | | | | 102,714,376 | | | | | | (h) | | | | | | 104,691,147 | | |
|
Estimated IKONICS shares outstanding(1)
|
| | | | 1,979,354 | | |
|
Estimated RSUs and stock options subject to accelerated vesting(2)
|
| | | | 102,244 | | |
|
Subtotal
|
| | | | 2,081,598 | | |
|
Cash consideration (per IKONICS share)
|
| | | $ | 5.00 | | |
|
Estimated share-based cash portion of purchase price
|
| | | $ | 10,407,990 | | |
|
Contingent Value Rights
|
| | | $ | 10,142,967 | | |
|
Estimated TeraWulf enterprise value
|
| | | $ | 2,700,000,000 | | |
|
Estimated shares at consummation of the mergers(3)
|
| | | $ | 104,691,147 | | |
|
Implied Holdco share price
|
| | | $ | 25.79 | | |
|
Estimated IKONICS shares outstanding(1)
|
| | | | 1,979,354 | | |
|
Estimated RSUs and stock options subject to accelerated vesting(2)
|
| | | | 102,244 | | |
|
Subtotal
|
| | | | 2,081,598 | | |
|
Equity portion of purchase price
|
| | | $ | 53,684,717 | | |
|
Total estimated consideration to be paid
|
| | | $ | 74,235,674 | | |
|
Shares issued to TeraWulf stockholders
|
| | | | 101,998,302 | | |
|
Shares issued to IKONICS stockholders
|
| | | | 2,081,598 | | |
|
Shares issued under awards to employees of Beowulf E&D
|
| | | | 611,247 | | |
| | | | | | 104,691,147 | | |
| | |
Implied Holdco
share price |
| |
Purchase Price
(equity portion) |
| ||||||
As presented
|
| | | $ | 25.79 | | | | | $ | 53,684,717 | | |
10% increase
|
| | | | 28.37 | | | | | | 59,054,935 | | |
10% decrease
|
| | | | 23.21 | | | | | | 48,313,890 | | |
20% increase
|
| | | | 30.95 | | | | | | 64,425,458 | | |
20% decrease
|
| | | | 20.63 | | | | | | 42,943,367 | | |
50% increase
|
| | | | 38.69 | | | | | | 80,537,027 | | |
50% decrease
|
| | | | 12.90 | | | | | | 26,852,614 | | |
|
Cash
|
| | | $ | 4,428,269 | | |
|
Trade receivables, net
|
| | | | 1,545,527 | | |
|
Inventories
|
| | | | 1,961,916 | | |
|
Prepaid expenses and other assets
|
| | | | 228,644 | | |
|
Property, plant and equipment, net
|
| | | | 7,227,802 | | |
|
Goodwill and acquired intangible assets
|
| | | | 62,917,908 | | |
|
Long-term debt
|
| | | | (2,654,019) | | |
|
Accounts payable and accrued liabilities
|
| | | | (1,420,373) | | |
|
Total estimated consideration
|
| | | $ | 74,235,674 | | |
|
Shares attributed to IKONICS common stock conversion
|
| | | | 2,081,598 | | |
|
Aggregate TeraWulf share amount – multiple of IKONICS attributed shares
|
| | | | 49 | | |
|
Aggregate TeraWulf share amount
|
| | | | 101,998,302 | | |
|
Less: number of outstanding TeraWulf shares
|
| | | | 50,000,000 | | |
|
Incremental TeraWulf shares
|
| | | | 51,998,302 | | |
|
Par value
|
| | | $ | 0.001 | | |
|
Incremental TeraWulf shares at par value
|
| | | $ | 51,998 | | |
|
Value of share awards due to Beowulf E&D employees
|
| | | $ | 12,500,000 | | |
|
IKONICS share price(1)
|
| | | $ | 20.45 | | |
|
Shares issued under awards to Beowulf E&D employees
|
| | | | 611,247 | | |
|
Par value
|
| | | $ | 0.001 | | |
|
Shares issued under awards to Beowulf E&D employees at par value
|
| | | $ | 611 | | |
|
Shares issued to TeraWulf stockholders
|
| | | | 101,998,302 | | |
|
Shares issued to IKONICS holders of RSUs or stock options
|
| | | | 104,827 | | |
|
Shares issued under awards to employees of Beowulf E&D
|
| | | | 611,247 | | |
| | | | | | 102,714,376 | | |
| | |
IKONICS
Common Stock |
| |||
June 24, 2021
|
| | | $ | 11.30 | | |
July 28, 2021
|
| | | $ | 22.37 | | |
| | |
Year Ending December 31,
|
| |||||||||
(amounts reflect rounding)
|
| |
2021E
|
| |
2022E
|
| ||||||
GROSS SALES
|
| | | $ | 15,820,288 | | | | | $ | 18,405,985 | | |
Customer credits
|
| | | | (169,536) | | | | | | (196,964) | | |
Prepaid freight
|
| | | | 374,647 | | | | | | 429,291 | | |
Discounts allowed
|
| | | | (112,259) | | | | | | (127,665) | | |
NET SALES
|
| | | | 15,913,140 | | | | | | 18,510,647 | | |
Cost of goods sold
|
| | | | 10,678,849 | | | | | | 12,343,092 | | |
GROSS PROFIT
|
| | | | 5,234,291 | | | | | | 6,167,556 | | |
Percent of net sales
|
| | | | 32.9% | | | | | | 33.3% | | |
DIRECT DIVISION SALES EXPENSES
|
| | | | 2,600,147 | | | | | | 2,774,889 | | |
NET INCOME
|
| | | | 2,634,144 | | | | | | 3,392,667 | | |
Percent of net sales
|
| | | | 16.6% | | | | | | 18.3% | | |
CORPORATE EXPENSES: | | | | | | | | | | | | | |
Administrative
|
| | | | 2,302,510 | | | | | | 2,348,560 | | |
Research & development
|
| | | | 583,073 | | | | | | 594,735 | | |
Marketing services
|
| | | | 13,242 | | | | | | 13,507 | | |
Interest expense
|
| | | | 102,304 | | | | | | — | | |
Interest income
|
| | | | (5,169) | | | | | | (5,272) | | |
Miscellaneous expense (income) & discounts
|
| | | | 13,355 | | | | | | (13,622) | | |
(Gain) loss on sale of assets
|
| | | | — | | | | | | — | | |
(Gain) loss – other
|
| | | | — | | | | | | — | | |
TOTAL CORPORATE EXPENSES
|
| | | | 2,982,605 | | | | | | 2,937,907 | | |
PRETAX (LOSS) INCOME
|
| | | | (348,461) | | | | | | 454,760 | | |
Income Taxes
|
| | | | (20,347) | | | | | | — | | |
NET (LOSS) INCOME
|
| | | $ | (328,114) | | | | | $ | 454,760 | | |
| | |
Forecasts for Year Ending December 31,
|
| |||||||||||||||||||||||||||||||||||||||
(in millions, amounts reflect rounding)
|
| |
2021E
|
| |
2022E
|
| |
2023E
|
| |
2024E
|
| |
2025E
|
| |
2026E
|
| |
2027E
|
| |||||||||||||||||||||
Revenue
|
| | | $ | 10.0 | | | | | $ | 437.2 | | | | | $ | 806.6 | | | | | $ | 955.2 | | | | | $ | 929.5 | | | | | $ | 978.9 | | | | | $ | 1,017.3 | | |
Gross profit
|
| | | $ | 9.0 | | | | | $ | 379.3 | | | | | $ | 699.6 | | | | | $ | 793.0 | | | | | $ | 739.8 | | | | | $ | 782.2 | | | | | $ | 816.6 | | |
Net income
|
| | | $ | 3.2 | | | | | $ | 209.0 | | | | | $ | 396.3 | | | | | $ | 392.0 | | | | | $ | 310.7 | | | | | $ | 345.5 | | | | | $ | 435.7 | | |
EBITDA(1) | | | | $ | 7.9 | | | | | $ | 353.4 | | | | | $ | 653.0 | | | | | $ | 727.0 | | | | | $ | 663.9 | | | | | $ | 704.4 | | | | | $ | 737.4 | | |
Capital expenditures
|
| | | $ | 367.9 | | | | | $ | 366.2 | | | | | $ | 581.8 | | | | | $ | 219.1 | | | | | $ | 0.0 | | | | | $ | 0.0 | | | | | $ | 0.0 | | |
Closed
|
| |
Acquiror
|
| |
Target
|
|
December 2020 | | | Avery Dennison Corporation | | | ACPO, Ltd. | |
December 2020 | | | good natured Products Inc. | | | IPF Holdings Inc. | |
November 2020 | | | Fitesa S.A. | | | Tredegar Corporation (Personal Care Films Business) | |
September 2020 | | | Essentra plc | | | 3C! Packaging, Inc. | |
April 2020 | | | TriMas Corporation | | | Rapak, LLC | |
March 2020 | | | Schweitzer-Mauduit International, Inc. | | | Trient LLC and Tekra LLC | |
December 2019 | | | Sonoco Products Company | | | Thermoform Engineered Quality, LLC, and Plastique Holdings, LTD | |
July 2019 | | | Tiarco, LLC | | | H.B. Fuller Company (Surfactants, Thickeners and Dispersants Business) | |
June 2019 | | | Sinomine (Hong Kong) Rare Metals Resources Co. Limited | | | Cabot Corporation (Specialty Fluids Business) | |
August 2018 | | | Sealed Air Corporation | | | Austin Foam Plastics, Inc. | |
July 2018 | | | CCL Industries Inc. | | | Treofan America, Inc. and Trespaphan Mexico Holdings GmbH | |
|
Average Approximate Implied Aggregate Equity Value
Reference Range for IKONICS Standalone (“Has”) |
| |
Average Approximate Implied Aggregate Reference
Range for Merger Consideration (“Gets”) |
|
|
$7.0 million – $29.1 million
|
| |
$50.4 million – $117.1 million
|
|
Name and Principal Position
|
| |
Cash(a)
($) |
| |
Equity(b)
($) |
| |
Perquisites/
Benefits(c) ($) |
| |
Other(d)
($) |
| |
Total
($) |
| |||||||||||||||
Glenn Sandgren
|
| | | | 275,000 | | | | | | 663,803 | | | | | | 18,000 | | | | | | — | | | | | | 956,803 | | |
Chief Executive Officer
|
| | | | | | |||||||||||||||||||||||||
Claude P. Piguet
|
| | | | — | | | | | | 349,469 | | | | | | — | | | | | | 50,000 | | | | | | 399,469 | | |
Executive Vice President
|
| | | | | | |||||||||||||||||||||||||
Kenneth Hegman
|
| | | | — | | | | | | 349,469 | | | | | | — | | | | | | 50,000 | | | | | | 399,469 | | |
Chief Operating Officer
|
| | | | | | |||||||||||||||||||||||||
William C. Ulland
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Former President and Chief Executive Officer
|
| | | | | |
Name
|
| |
Age
|
| |
Position
|
|
Paul Prager | | |
62
|
| | Chief Executive Officer and Chair of the Board of Directors | |
Kenneth Deane | | |
52
|
| | Chief Financial Officer | |
Nazar Khan | | |
45
|
| | Chief Operating Officer, Chief Technology Officer and Executive Director | |
Kerri Langlais | | |
44
|
| | Chief Strategy Officer | |
Walter Carter | | |
62
|
| | Director | |
Catherine “Cassie” Motz | | |
50
|
| | Director | |
Jason New | | |
52
|
| | Director | |
Steven Pincus | | |
63
|
| | Director | |
Lisa Prager | | |
64
|
| | Director | |
Name and Principal Position
|
| |
Base Salary
($) |
| |
Target Bonus
(% of Base Salary) |
| |
Target Bonus
($) |
| |||||||||
Paul Prager
|
| | | | 950,000 | | | | | | 150% | | | | | | 1,425,000 | | |
Chief Executive Officer
|
| | | | | | | | | | | | | | | | | | |
Kenneth Deane
|
| | | | 325,000 | | | | | | 25% | | | | | | 81,250 | | |
Chief Financial Officer
|
| | | | | | | | | | | | | | | | | | |
Nazar Khan
|
| | | | 450,000 | | | | | | 100% | | | | | | 450,000 | | |
Chief Operating Officer and Chief Technology Officer
|
| | | | | | | | | | | | | | | | | | |
Kerri Langlais
|
| | | | 400,000 | | | | | | 50% | | | | | | 200,000 | | |
Chief Strategy Officer
|
| | | | | | | | | | | | | | | | | | |
|
•
Cash retainer
|
| | $60,000 | |
|
•
Lead independent director
(additional cash retainer)
|
| | $25,000 | |
|
•
Committee chairmanship
(additional cash retainers)
|
| |
Audit Committee Chair: $25,000
Compensation Committee Chair: $25,000 |
|
| Restricted stock units vest on the first anniversary of the date of grant | | |
Each non-employee director will receive an annual grant of restricted stock units with a grant date value of $90,000
The lead independent director will receive an additional annual grant of restricted stock units with a grant date value of $25,000
|
|
| | |
IKONICS Common Stock
|
| |||
June 24, 2021
|
| | | $ | 11.30 | | |
July 28, 2021
|
| | | $ | 22.37 | | |
|
Authorized Capital Stock
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| 5,000,000 million, of which (1) 4,750,000 million are shares of common stock, par value $0.10 per share, and (2) 250,000 million are shares of preferred stock, par value $0.01 per share. | | | 225 million, of which (1) 200 million are shares of common stock, par value of $0.001 per share, and (2) 25 million are shares of preferred stock, par value $0.001 per share. | |
|
Size of the Board of Directors
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Subject to the rights of the holders of preferred stock to elect additional directors under certain circumstances, the number of directors on the IKONICS board of directors is at least five (5) and no more nine (9) directors. | | | The number of directors of Holdco shall not be less than three (3) nor more than ten (10) members as determined from time to time by the Holdco board of directors in accordance with the rights of certain stockholders pursuant to a letter agreement between Stammtisch and AOW, which we refer to herein as the “stockholders agreement.” | |
| IKONICS currently has eight (8) directors. | | | Holdco will have directors upon the closing of the mergers. | |
|
Removal of Directors
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Any director may be removed for cause by an affirmative vote by shareholders of a majority of the shares then entitled to vote on the election of directors; provided however that notice of any such meeting convened for the purpose of removing a director will contain a statement of the intention to remove the director and a summary of the basis for the proposed removal and be served on such director not less than 30 days before such meeting and at such meeting the director will be entitled to be heard on the motion for such director’s removal. | | |
Holdco’s amended and restated certificate of incorporation does not contain any special provisions regarding the removal of directors.
Under the DGCL, a director may be removed from office, with or without cause, by the holders of a majority of the shares entitled to vote at an election of directors.
|
|
|
Cumulative Voting
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| None. | | | None. | |
|
Classes of Directors
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| There are three (3) classes of directors, each class to be as nearly equal in number as possible. One class of directors is elected each year, and the term of each class of directors expires at the third (3rd) annual meeting of shareholders after their election by the shareholders. | | | All directors are elected annually and serve until each such director’s successor is elected and qualified. | |
|
Vacancies on the Board
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Vacancies, including as a result of an increase in the number of directors, may be filled by the affirmative vote of a majority of the remaining directors in office, though less than a quorum. | | | Holdco’s amended and restated bylaws provides that any newly created directorships resulting from an increase in the authorized number of directors and any vacancies occurring in the Holdco board of directors may be filled solely by a majority of the Holdco directors then in office, although less than a quorum, or a sole remaining director. | |
| Whenever the holders of any class of shares are entitled to elect one or more directors, any newly created directorships of such class to be filled as a result of an increase in the number of directors may be filled by the affirmative vote of a majority of the directors elected by such class or series then in office or by a sole remaining director so elected, or by vote of the holders of the outstanding shares of such class or series. | | | Holdco’s amended and restated bylaws provide that, subject to the rights of certain stockholders set forth in a stockholders agreement and the rights of a majority of the directors appointed by Stammtisch to the Holdco board to appoint the Chairperson of the board of directors for so long as Stammtisch beneficially owns in the aggregate (directly or indirectly) at least fifteen percent (15%) or more of the voting power of the then outstanding shares of capital stock of Holdco, when one or more directors resign from the Holdco board, effective at a future time, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancies. | |
|
Board Quorum and Vote Requirements
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| A majority of the entire number of directors constitutes a quorum. The act of the majority of directors present at a meeting at which there is a quorum constitutes action by the board of directors. | | | Holdco’s amended and restated bylaws provide that the presence of a majority of the total number of directors of Holdco then in office shall constitute a quorum for the transaction of business at any meeting of the board, provided, however, than in no case shall a quorum consist of less than one-third of the total number of directors of Holdco that would have had if there were no vacancies on the Holdco board of directors. If a quorum shall not be present at any meeting of the Holdco board of directors, the directors present thereat may, to the fullest extent permitted by law, adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present. | |
|
Annual Meetings of Shareholders
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Date, time and place of the annual meeting is determined by the board of directors. | | | Date, time and place of the annual meeting is determined by the board of directors. | |
| Written notice of the annual meeting must be given to shareholders personally, via mail, or via electronic transmission not less than ten (10) nor more than 60 days prior to the meeting, except in the event of a merger, conversion, consolidation in which the corporation is a constituent corporation, or the sale of all or substantially all of the assets of IKONICS requiring shareholder approval, in which case notice must be given to shareholders at least twenty (20) days prior to the meeting. | | | Written notice of any meeting of the shareholders shall be either mailed or electronically transmitted to shareholders entitled to vote at such meeting not less than ten (10) nor more than sixty (60) days prior to the meeting. | |
|
Special Meetings of Shareholders
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Special meetings may be called by the Chief Executive Officer, the chair of the board of directors, or the board of directors. Additionally, so long as Ascribe and Solace (together with certain funds or accounts advised by them) own at least 25% of the issued and outstanding IKONICS common stock entitled to vote at such meeting, a special meeting of the shareholders shall be called by the Secretary upon the written request a shareholder or shareholders holding at least 30% of the voting power of the issued and outstanding common stock entitled to vote at such meeting. | | |
Special meetings may be called by the Holdco board of directors, at the request of the Chairperson of the Holdco board of directors upon written request by Stammtisch at any time prior to the first date on which Stammtisch and Stammtisch Affiliates cease to beneficially own in the aggregate (directly or indirectly) shares of capital stock entitled to vote generally for the election of directors of the Corporation representing at least fifteen percent (15%) of such shares of capital stock owned by Stammtisch and Stammtisch Affiliates as of the date of the closing of the mergers or by the Secretary upon proper written request or requests given by or on behalf of one or more shareholders of Holdco who hold at least fifty percent (50%) of the voting power of all outstanding shares of Holdco common stock (the date of any such shareholder meeting shall be no more than ninety (90) days after the Secretary receives the foregoing request or requests from shareholders of Holdco)
Notwithstanding the foregoing, a special meeting shall not be held if the board of directors calls for an annual meeting to be held within ninety (90) days after the Secretary receives the request for the special meeting and the board determines in good faith that the business of such annual meeting includes the business specified in the special meeting request.
|
|
|
Quorum Requirements for Shareholder Meetings
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| A majority of the outstanding shares of voting stock, represented in person or by proxy, constitutes a quorum at any meeting of shareholders. | | | The amended and restated Holdco bylaws provide that the presence, in person or represented by proxy, of the holders of at least a majority of the voting power of all outstanding shares of stock entitled to vote at the meeting of Holdco shareholders shall | |
|
Quorum Requirements for Shareholder Meetings
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| | | | constitute a quorum for the transaction of business at such meeting of shareholders, except that when specified business is to be voted on by one or more classes or series of stock voting as a separate class, the holders of a majority of the voting power of the shares of such classes or series shall constitute a quorum of such separate class for the transaction of such business at such a meeting of shareholders of Holdco. | |
|
Voting Standards
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Except as otherwise required by law, the affirmative vote of a majority of the votes cast at a meeting of shareholders constitutes the act of the shareholders in all matters other than the election of directors. Where the number of persons validly proposed for election or re-election as a director is greater than the number of directors to be elected, the persons receiving the most votes, up to the number of directors to be elected, are elected as directors. | | |
Each holder of Holdco common stock shall have the right to one (1) vote per share of Class A common stock and shall be entitled to vote upon such matters and in such manner as provided by applicable law.
In all matters other than the election of directors and except as otherwise required by law, the affirmative vote of a majority of votes cast at a meeting of shareholders constitutes the act of the shareholders. The amended and restated Holdco bylaws provide that directors shall be elected by will be elected by a plurality of the votes cast.
|
|
|
Shareholder Action by Written Consent
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| Shareholder action by written consent is not permitted. | | | Under the DGCL, any action that may be taken at any annual or special meeting of the shareholders may be taken by written consent of holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize such action at a meeting at which all shares entitled to vote thereon were present and voted, which right to act by written consent may be limited by express provision set forth in a corporation’s certificate of incorporation. The amended and restated certificate of incorporation of Holdco expressly provides that the shareholders of Holdco may not take action by written consent in lieu of a meeting of Holdco shareholders. | |
|
Notice Requirements for Shareholder Nominations and Other Proposals
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| To bring a matter before an annual meeting, including nominations of directors, a shareholder must give notice or the proposed matter or nomination not less than ninety (90) and not more than one hundred fifty (150) days prior to the one (1) year anniversary of the preceding annual meeting. | | | To bring a matter before an annual meeting, including nominations of directors, a shareholder must give notice of the proposed matter or nomination not less than 120 days and not more than 90 days prior to the one-year anniversary of the preceding annual meeting. | |
|
Notice Requirements for Shareholder Nominations and Other Proposals
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| If the annual meeting is not within thirty (30) days before or thirty (30) days after the anniversary date of the preceding annual meeting, the shareholder notice must be received not less than ninety (90) and not more than one hundred fifty (150) days before such annual meeting or on or before the tenth (10th) day following the day on which notice of the annual meeting was announced publicly. | | | If the annual meeting is more than thirty (30) days before or more than sixty (60) days after the anniversary date of the preceding annual meeting, the shareholder notice must be received not less than 30 days prior to such annual meeting or, if later, not less than the tenth (10th) day following the day on which notice of the annual meeting was announced publicly. | |
|
Takeover Restrictions
|
| |||
|
IKONICS
|
| |
Holdco
|
|
|
The Restated Articles of Incorporation generally prohibit IKONICS from engaging in significant business transactions (including a merger or consolidation) with a holder of 15% or more of IKONICS’ stock (referred to as an interested shareholder) for a period of three (3) years after the interested shareholder becomes an interested shareholder, unless:
•
prior to the time the shareholder became an interested shareholder, the board approved either the business combination or the transaction which resulted in the shareholder becoming an interested shareholder;
•
upon consummation of the transaction which resulted in the shareholder becoming an interested shareholder, the interested shareholder owned at least 85% of the voting stock of the corporation, excluding specified shares; or
•
at or subsequent to the time the shareholder became an interested shareholder, the business combination is approved by the board and authorized at an annual or special meeting of shareholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested shareholder.
|
| |
Holdco’s amended and restated certificate of incorporation does not contain any super-majority voting requirements governing mergers, consolidations, sales of substantially all of Holdco’s assets, liquidations, reclassifications or recapitalizations.
Subject to certain exceptions, Section 203 of the DGCL generally prohibits public corporations from engaging in significant business transactions, including mergers, with a holder of 15% or more of the corporation’s stock, referred to as an interested shareholder, for a period of three (3) years after the interested shareholder becomes an interested shareholder. Holdco has not opted out of Section 203 in its amended and restated certificate of incorporation.
|
|
| IKONICS has elected not to be governed by Section 203 of the DGCL. | | | | |
|
Rights Plan
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| IKONICS has not adopted a rights plan. | | | Holdco has not adopted a rights plan. | |
|
Amendments to the Certificate of Incorporation
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| The certificate of incorporation can only be amended or repealed by the affirmative vote of the holders of at least 66 2/3% of the shares entitled to | | | Holdco’s amended and restated certificate of incorporation does not contain any special provisions regarding the approval of amendments to | |
|
Amendments to the Certificate of Incorporation
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| vote thereon. However, the affirmative vote of the holders of at least 80% of the shares entitled to vote thereon is required to amend or repeal the sections of the articles of incorporation governing the number and classification of directors. | | |
the amended and restated certificate of incorporation.
Under Delaware law, approval of a majority of the outstanding stock entitled to vote is required to amend a corporation’s certificate of incorporation.
|
|
|
Amendments to the Bylaws
|
| |||
|
IKONICS
|
| |
Holdco
|
|
| The board of directors is expressly empowered to adopt, amend or repeal the IKONICS bylaws. In addition any amendment, repeal, or adoption of any provision inconsistent with IKONICS’ bylaws by the IKONICS shareholders requires the affirmative vote of at least 66 2/3% of the voting power of the issued and outstanding common stock entitled to vote generally in the election of directors, voting together as a single class. | | | Subject to the Stockholders Agreement of Holdco, by and among the certain stockholders the board of directors is expressly empowered to adopt, amend, or repeal Holdco’s bylaws. Holdco’s amended and restated bylaws provide that certain provisions of Holdco’s amended and restated bylaws may not be amended other than with the prior written consent of Stammtisch for so long as Stammtisch owns at least fifteen percent (15%) or more of the issued and outstanding voting securities of Holdco. | |
|
Limitation of Personal Liability of Directors, Officers and Employees
|
| |||
|
IKONICS
|
| |
Holdco
|
|
|
A director will not be personally liable to the company for monetary damages for breach of fiduciary duty as a director, except for liability:
•
for any breach of the director’s duty of loyalty to IKONICS or its shareholders,
•
for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,
•
for unlawful payment of dividends or unlawful redemptions or repurchases under Section 174 of the DGCL, or
•
for any transaction from which the director derived an improper personal benefit. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of IKONICS will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.
|
| | Same as IKONICS. | |
Name and Address of Beneficial Owner(1)
|
| |
Pre-Mergers
TeraWulf Common Stock |
| |||||||||
|
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| ||||||||
Directors and Executive Officers of TeraWulf: | | | | | | | | | | | | | |
Paul Prager
|
| | | | 10,890,000 | | | | | | 21.8% | | |
Kenneth Deane
|
| | | | — | | | | | | — | | |
Nazar Khan
|
| | | | 6,898,000 | | | | | | 13.8% | | |
Kerri Langlais
|
| | | | 1,210,000 | | | | | | 2.4% | | |
All directors and current executive officers (4 persons)
|
| | | | 18,998,000 | | | | | | 38.0% | | |
Significant Shareholders: | | | | | | | | | | | | | |
Stammtisch Investments LLC
|
| | | | 17,284,488 | | | | | | 34.6% | | |
AOW Capital LLC
|
| | | | 19,800,000 | | | | | | 39.6% | | |
Name and Address of Beneficial Owner(1)
|
| |
Post-Mergers
Holdco Common Stock |
| |||
|
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| ||
Directors and Executive Officers of TeraWulf: | | | | | | | |
Paul Prager
|
| | | | | | |
Kenneth Deane
|
| | | | | | |
Nazar Khan
|
| | | | | | |
Kerri Langlais
|
| | | | | | |
Walter Carter
|
| | | | | | |
Catherine “Cassie” Motz
|
| | | | | | |
Jason New
|
| | | | | | |
Steven Pincus
|
| | | ||||
Lisa Prager
|
| | | | | | |
All directors and current executive officers (8 persons)
|
| | | | | | |
Significant Shareholders of Holdco Common Stock: | | | | | | | |
Stammtisch Investments LLC
|
| | | | | | |
AOW Capital LLC
|
| | | | | | |
Name and Address of Beneficial Owner(1)
|
| |
Pre-Mergers
IKONICS Common Stock |
| |||||||||
|
Number of
Shares(2) |
| |
Percentage of
Outstanding Shares |
| ||||||||
Directors and Executive Officers: | | | | | | | | | | | | | |
William C. Ulland
|
| | | | 243,047(3) | | | | | | 12.3% | | |
Darrell B. Lee
|
| | | | 10,211 | | | | | | * | | |
Ernest M. Harper, Jr.
|
| | | | — | | | | | | — | | |
Lockwood Carlson
|
| | | | 250 | | | | | | * | | |
Marianne Bohren
|
| | | | 100 | | | | | | * | | |
Jeffrey D. Engbrecht
|
| | | | — | | | | | | — | | |
Gregory W. Jackson
|
| | | | — | | | | | | — | | |
Glenn Sandgren
|
| | | | 5,833(4) | | | | | | * | | |
Claude P. Piguet
|
| | | | 21,675 | | | | | | 1.1% | | |
Ken Hegman
|
| | | | 375 | | | | | | * | | |
All directors and current executive officers (11 persons)
|
| | | | 291,908 | | | | | | 14.7% | | |
Significant Shareholders: | | | | | | | | | | | | | |
Joseph R. Nerges 1726 Bundy Street Scranton, PA 18508
|
| | | | 318,779(5) | | | | | | 16.1% | | |
H. Leigh Severance 100 Fillmore Street, Suite 300 Denver, CO 80206
|
| | | | 180,079(6) | | | | | | 9.1% | | |
Gerald W. Simonson 7260 Commerce Circle East Minneapolis, Minnesota 55432
|
| | | | 125,495(7) | | | | | | 6.4% | | |
| | |
Page
|
| |||
| | | | A-6 | | | |
| | | | A-6 | | | |
| | | | A-6 | | | |
| | | | A-6 | | | |
| | | | A-7 | | | |
| | | | A-7 | | | |
| | | | A-7 | | | |
| | | | A-8 | | | |
| | | | A-8 | | | |
| | | | A-8 | | | |
| | | | A-9 | | | |
| | | | A-11 | | | |
| | | | A-13 | | | |
| | | | A-13 | | | |
| | | | A-13 | | | |
| | | | A-14 | | | |
| | | | A-14 | | | |
| | | | A-14 | | | |
| | | | A-14 | | | |
| | | | A-15 | | | |
| | | | A-16 | | | |
| | | | A-16 | | | |
| | | | A-16 | | | |
| | | | A-16 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-18 | | | |
| | | | A-19 | | | |
| | | | A-20 | | | |
| | | | A-21 | | | |
| | | | A-21 | | | |
| | | | A-23 | | | |
| | | | A-23 | | | |
| | | | A-23 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-25 | | |
| | |
Page
|
| |||
| | | | A-25 | | | |
| | | | A-25 | | | |
| | | | A-25 | | | |
| | | | A-26 | | | |
| | | | A-27 | | | |
| | | | A-27 | | | |
| | | | A-28 | | | |
| | | | A-29 | | | |
| | | | A-29 | | | |
| | | | A-29 | | | |
| | | | A-29 | | | |
| | | | A-31 | | | |
| | | | A-32 | | | |
| | | | A-33 | | | |
| | | | A-34 | | | |
| | | | A-34 | | | |
| | | | A-35 | | | |
| | | | A-36 | | | |
| | | | A-36 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-39 | | | |
| | | | A-41 | | | |
| | | | A-42 | | | |
| | | | A-45 | | | |
| | | | A-46 | | | |
| | | | A-46 | | | |
| | | | A-46 | | | |
| | | | A-48 | | | |
| | | | A-48 | | | |
| | | | A-49 | | | |
| | | | A-49 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-50 | | | |
| | | | A-51 | | |
| | |
Page
|
| |||
| | | | A-51 | | | |
| | | | A-51 | | | |
| | | | A-51 | | | |
| | | | A-51 | | | |
| | | | A-52 | | | |
| | | | A-53 | | | |
| | | | A-53 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-54 | | | |
| | | | A-55 | | | |
| | | | A-55 | | | |
| | | | A-56 | | | |
| | | | A-56 | | | |
| | | | A-63 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-65 | | | |
| | | | A-65 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-68 | | | |
| | | | A-68 | | |
Term
|
| |
Section
|
|
Adjusted RSU Award | | | 2.3(c) | |
Agreement | | | Preamble | |
Aggregate Company Share Amount | | | 8.1(b) | |
Alternative Acquisition Agreement | | | 5.4(c)(vi) | |
Assumed Shares | | | 2.3(d) | |
Balance Sheet Date | | | 3.9(a) | |
Closing | | | 1.2 | |
Closing Date | | | 1.2 | |
Code | | | 2.2(f) | |
Company | | | Preamble | |
Company Benefit Plan | | | 3.13(a) | |
Company Board | | | Recitals | |
Company Board Recommendation | | | Recitals | |
Company Book-Entry Shares | | | 2.1(e) | |
Company Disclosure Letter | | | Article III | |
Company Financing | | | 5.18(a) | |
Company Intellectual Property | | | 3.17(a) | |
Company Material Contract | | | 3.12(a) | |
Company Merger Consideration | | | 2.1(c)(i) | |
Company Name Change | | | 1.5(c) | |
Company Organizational Documents | | | 3.2 | |
Company Owned Intellectual Property | | | 3.17(b) | |
Company Permits | | | 3.19(a) | |
Company Real Property | | | 3.18(a) | |
Company Real Property Leases | | | 3.18(b) | |
Company Related Parties | | | 7.6(d)(ii) | |
Company Response Action | | | 5.1 | |
Company Stock Certificates | | | 2.1(e) | |
Company Termination Fee | | | 7.6(c) | |
Company Voting Agreement | | | Recitals | |
Covered Persons | | | 5.17(a) | |
CVR Agreement | | | Recitals | |
DGCL | | | Recitals | |
Dissenting Shares | | | 2.4(a) | |
Effect | | | 8.1(i) | |
ERISA | | | 3.13(a) | |
Exchange Act | | | 3.3(b) | |
Exchange Agent | | | 2.2(a) | |
Exchange Fund | | | 2.2(b) | |
Exchange Ratio | | | 2.1(c)(i) | |
Excluded Company Shares | | | 2.1(c)(iii) | |
Term
|
| |
Section
|
| | ||
Expenses | | | 5.12 | | | ||
Fair Market Value | | | 2.3(a) | | | ||
First Certificate of Merger | | | 1.3(a) | | | ||
First Effective Time | | | 1.3(a) | | | | |
First Merger | | | Recitals | | | | |
Fully Diluted Basis | | | 8.1(u) | | | | |
Governmental Authorizations | | | 3.3 | | | | |
HoldCo | | | Preamble | | | | |
HoldCo Certificate of Incorporation | | | 1.5(d) | | | | |
Indemnified Parties | | | 5.8(a) | | | | |
Insurance Policies | | | 3.23 | | | | |
Intended Tax Treatment | | | 1.7 | | | | |
IRS | | | 3.13(b) | | | | |
Legacy Sale | | | Recitals | | | | |
Legal Actions | | | 3.11 | | | | |
Liabilities | | | 3.9 | | | | |
Maximum Company Liability Amount | | | 7.6(d)(ii) | | | | |
Maximum Parent Liability Amount | | | 7.6(d)(i) | | | | |
MBCA | | | Recitals | | | | |
Merger Sub I | | | Preamble | | | | |
Merger Sub II | | | Preamble | | | | |
Parent Financial Advisor | | | 4.25 | | | | |
Parent | | | Preamble | | | | |
Parent Adverse Recommendation Change | | | 5.4(c)(v) | | | | |
Parent Benefit Plan | | | 4.14(a) | | | | |
Parent Board | | | Recitals | | | | |
Parent Board Recommendation | | | Recitals | | | | |
Parent Book-Entry Shares | | | 2.1(d) | | | | |
Parent Cash Consideration | | | 2.1(a)(i) | | | | |
Parent Disclosure Letter | | | Article IV | | | | |
Parent Entities | | | Preamble | | | | |
Parent Insurance Policies | | | 4.24 | | | | |
Parent Intellectual Property | | | 4.18(a) | | | | |
Parent Material Contract | | | 4.13(a) | | | | |
Parent Merger Consideration | | | 2.1(a)(i) | | | | |
Parent Organizational Documents | | | 4.2 | | | | |
Parent Owned Intellectual Property | | | 4.18(b) | | | | |
Parent Permits | | | 4.20(a) | | | | |
Parent Real Property | | | 4.19(a) | | | | |
Parent Real Property Leases | | | 4.19(b) | | | | |
Parent Registered IP | | | 4.18(a) | | | | |
Parent Registration Statement | | | 4.3(b) | | | | |
Parent Related Parties | | | 7.6(d)(i) | | | | |
Term
|
| |
Section
|
| | | ||||
Parent Response Action | | | 5.2 | | | | | | ||
Parent RSU Award | | | 2.3(b) | | | | | | ||
Parent SEC Reports | | | 4.8(a) | | | | | | ||
Parent Share Consideration | | | 2.1(a)(i) | | | | | | ||
Parent Stock Certificates | | | 2.1(d) | | | | | | ||
Parent Stock Option | | | 2.3(a) | | | | | | ||
Parent Surviving Company | | | 1.1(a) | | | | | | ||
Parent Termination Fee | | | 7.6(b) | | | | | | ||
Parent Voting Agreement | | | Recitals | | | | | | ||
Permits | | | 3.19(a) | | | | | | ||
Predecessor | | | 8.1(ww) | | | | | | ||
Registered IP | | | 3.17(a) | | | | | | ||
Residual Shares | | | 2.3(d) | | | | | | ||
Rights Agent | | | Recitals | | | | | | ||
SEC | | | 4.3(b) | | | | | | ||
Second Certificate of Merger | | | 1.3(b) | | | | | | ||
Second Effective Time | | | 1.3(b) | | | | | | ||
Second Merger | | | Recitals | | | | | | ||
Shareholder Litigation | | | 5.17(a) | | | | | | ||
Stock Equivalent | | | 8.1(fff) | | | | | | ||
Surviving Company | | | 1.1(b) | | | | | | ||
Termination Date | | | 7.2(a) | | | | | | ||
Transactions | | | Recitals | | | | | | ||
WARN Act | | | 3.14(c) | | | | | | ||
| | | | | | | | | | |
| | |
Page
|
| |||
| | | | G-3 | | | |
| | | | G-4 | | | |
| | | | G-11 | | | |
| | | | G-16 | | | |
| | | | G-16 | | | |
| | | | G-17 | | | |
| | | | G-18 | | | |
| | | | G-19 | | |
| | |
Page
|
| |||
TeraWulf Audited Financial Statements | | | | | | | |
| | | | H-4 | | | |
| | | | H-5 | | | |
| | | | H-6 | | | |
| | | | H-7 | | | |
| | | | H-8 | | | |
| | | | H-9 | | | |
IKONICS Unaudited Condensed Financial Statements | | | | | | | |
| | | | H-17 | | | |
| | | | H-18 | | | |
| | | | H-19 | | | |
| | | | H-20 | | | |
| | | | H-21 | | | |
IKONICS Audited Financial Statements | | | | | | | |
Report of Independent Registered Public Accounting Firm
|
| | | | | | |
| | | | H-27 | | | |
| | | | H-28 | | | |
| | | | H-29 | | | |
| | | | H-30 | | | |
| | | | H-31 | | |
| | |
Page
|
| |||
| | | | H-4 | | | |
Financial Statements as of March 31, 2021 and for the period February 8, 2021 (date of inception) to March 31, 2021:
|
| | | | | | |
| | | | H-5 | | | |
| | | | H-6 | | | |
| | | | H-7 | | | |
| | | | H-8 | | | |
| | | | H-9 | | |
| | |
2021
|
| |||
ASSETS | | | |||||
CURRENT ASSETS: | | | | | | | |
Cash and cash equivalents
|
| | | $ | 6,300 | | |
Other current assets
|
| | | | 5 | | |
Total current assets
|
| | | | 6,305 | | |
OTHER ASSETS: | | | | | | | |
Deposits
|
| | | | 23,700 | | |
TOTAL ASSETS
|
| | | $ | 30,005 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | |
CURRENT LIABILITIES: | | | | | | | |
Accounts payable and accrued liabilities
|
| | | $ | 1,739 | | |
Total current liabilities
|
| | | | 1,739 | | |
TOTAL LIABILITIES
|
| | | | 1,739 | | |
Commitments and Contingencies (See Note 5) | | | | | | | |
STOCKHOLDERS’ EQUITY: | | | | | | | |
Common stock, $0.001 par value, 100,000,000 authorized, 50,000,000 issued and
outstanding |
| | | | 50 | | |
Additional paid-in capital
|
| | | | 29,892 | | |
Accumulated deficit
|
| | | | (1,676) | | |
Total stockholders’ equity
|
| | | | 28,266 | | |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
| | | $ | 30,005 | | |
| | |
2021
|
| |||
Revenue
|
| | | $ | — | | |
Cost of operations: | | | | | | | |
Operating expense
|
| | | | 853 | | |
Selling, general and administrative
|
| | | | 823 | | |
Total cost of operations
|
| | | | 1,676 | | |
Operating loss
|
| | | | (1,676) | | |
Loss from operations before income taxes
|
| | | | (1,676) | | |
Income tax expense (benefit)
|
| | | | — | | |
Net loss
|
| | | $ | (1,676) | | |
Loss per common share: | | | | | | | |
Basic and diluted
|
| | | $ | (0.05) | | |
Weighted average common shares outstanding: | | | | | | | |
Basic and diluted
|
| | | | 32,923,077 | | |
| | |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Total
|
| ||||||||||||||||||
| | |
Number
|
| |
Amount
|
| ||||||||||||||||||||||||
Balances as of February 8, 2021
|
| | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of common stock, net of issuance
costs |
| | | | 50,000,000 | | | | | | 50 | | | | | | 29,892 | | | | | | — | | | | | | 29,942 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (1,676) | | | | | | (1,676) | | |
Balances as of March 31, 2021
|
| | | | 50,000,000 | | | | | $ | 50 | | | | | $ | 29,892 | | | | | $ | (1,676) | | | | | $ | 28,266 | | |
| | |
2021
|
| |||
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | |
Net loss
|
| | | $ | (1,676) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | |
Changes in operating assets and liabilities:
|
| | | | | | |
Increase in other current assets
|
| | | | (5) | | |
Increase in accounts payable and accrued liabilities
|
| | | | 1,681 | | |
Net cash provided by (used in) operating activities
|
| | | | — | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | |
Deposits on plant and equipment
|
| | | | (23,700) | | |
Net cash used in investing activities
|
| | | | (23,700) | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | |
Proceeds from issuance of common stock
|
| | | | 30,000 | | |
Net cash provided by financing activities
|
| | | | 30,000 | | |
Net change in cash and cash equivalents
|
| | | | 6,300 | | |
Cash and cash equivalents at beginning of period
|
| | | | — | | |
Cash and cash equivalents at end of period
|
| | | $ | 6,300 | | |
Supplemental disclosure of cash flow information: | | | | | | | |
Cash paid during the period for: | | | | | | | |
Interest
|
| | | $ | — | | |
Income taxes
|
| | | $ | — | | |
Non-cash investing and financing activities: | | | | | | | |
Common stock issuance costs in accrued liabilities
|
| | | $ | 58 | | |
| | |
2021
|
| |||
Deferred tax assets: | | | | | | | |
Net operating loss carryforwards
|
| | | $ | 461 | | |
Valuation allowance
|
| | | | (461) | | |
Total deferred tax assets
|
| | | $ | — | | |
| | |
2021
|
| |||
Current: | | | |||||
Federal
|
| | | $ | — | | |
State
|
| | | | — | | |
Foreign
|
| | | | — | | |
Total current expense (benefit)
|
| | | | — | | |
Deferred: | | | | | | | |
Federal
|
| | | | — | | |
State
|
| | | | — | | |
Foreign
|
| | | | — | | |
Total deferred expense (benefit)
|
| | | | — | | |
Total expense (benefit) for income taxes
|
| | | $ | — | | |
| | |
2021
|
| |||
Statutory US federal rate
|
| | | | 21.00% | | |
State income taxes, net of federal impact
|
| | | | 6.52% | | |
Change in valuation allowance
|
| | | | (27.52)% | | |
Effective income tax rate
|
| | | | 0.00% | | |
| | |
March 31,
2021 |
| |
December 31,
2020 |
| ||||||
| | |
(unaudited)
|
| | ||||||||
ASSETS | | | | | | | | | |||||
CURRENT ASSETS: | | | | | | | | | | | | | |
Cash
|
| | | $ | 4,428,269 | | | | | $ | 3,693,845 | | |
Trade receivables, less allowance of $54,000 in 2021 and $55,000 in 2020
|
| | | | 1,545,527 | | | | | | 2,119,213 | | |
Inventories
|
| | | | 1,961,916 | | | | | | 1,644,975 | | |
Prepaid expenses and other assets
|
| | | | 210,895 | | | | | | 125,969 | | |
Income taxes receivable
|
| | | | 17,749 | | | | | | 219,451 | | |
Total current assets
|
| | | | 8,164,356 | | | | | | 7,803,453 | | |
PROPERTY, PLANT, AND EQUIPMENT, at cost: | | | | | | | | | | | | | |
Land and building
|
| | | | 9,556,586 | | | | | | 9,556,586 | | |
Machinery and equipment
|
| | | | 5,263,586 | | | | | | 5,263,586 | | |
Office equipment
|
| | | | 1,417,219 | | | | | | 1,417,219 | | |
Vehicles
|
| | | | 245,674 | | | | | | 245,674 | | |
| | | | | 16,483,065 | | | | | | 16,483,065 | | |
Less accumulated depreciation
|
| | | | (9,255,263) | | | | | | (9,094,702) | | |
Total property, plant and equipment at cost, net
|
| | | | 7,227,802 | | | | | | 7,388,363 | | |
INTANGIBLE ASSETS, less accumulated amortization of $198,539 in 2021 and $207,399 in 2020
|
| | | | 243,819 | | | | | | 243,583 | | |
Total assets
|
| | | $ | 15,635,977 | | | | | $ | 15,435,399 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | |
CURRENT LIABILITIES | | | | | | | | | | | | | |
Current portion of long-term debt
|
| | | $ | 2,654,019 | | | | | $ | 2,688,396 | | |
Accounts payable
|
| | | | 872,679 | | | | | | 459,836 | | |
Accrued compensation
|
| | | | 359,596 | | | | | | 279,755 | | |
Other accrued liabilities
|
| | | | 188,098 | | | | | | 168,066 | | |
Total current liabilities
|
| | | | 4,074,392 | | | | | | 3,596,053 | | |
COMMITMENTS AND CONTINGENCIES | | | | | | | | | | | | | |
STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | |
Preferred stock, par value $.10 per share; authorized 250,000 shares;
issued none |
| | | | — | | | | | | — | | |
Common stock, par value $.10 per share; authorized 4,750,000 shares; issued and outstanding 1,977,104 shares in 2021 and
1,976,354, in 2020 |
| | | | 197,710 | | | | | | 197,635 | | |
Additional paid-in-capital
|
| | | | 2,787,733 | | | | | | 2,743,930 | | |
Retained earnings
|
| | | | 8,576,142 | | | | | | 8,897,781 | | |
Total stockholders’ equity
|
| | | | 11,561,585 | | | | | | 11,839,346 | | |
Total liabilities and stockholders’ equity
|
| | | $ | 15,635,977 | | | | | $ | 15,435,399 | | |
| | |
Three Months Ended
March 31, |
| |||||||||
| | |
2021
|
| |
2020
|
| ||||||
NET SALES
|
| | | $ | 3,073,408 | | | | | $ | 3,497,192 | | |
COST OF GOODS SOLD
|
| | | | 2,077,076 | | | | | | 2,343,960 | | |
GROSS PROFIT
|
| | | | 996,332 | | | | | | 1,153,232 | | |
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
|
| | | | 1,183,591 | | | | | | 1,781,020 | | |
RESEARCH AND DEVELOPMENT EXPENSES
|
| | | | 134,922 | | | | | | 183,580 | | |
LOSS FROM OPERATIONS
|
| | | | (322,181) | | | | | | (811,368) | | |
INTEREST EXPENSE
|
| | | | (19,842) | | | | | | (21,484) | | |
OTHER INCOME
|
| | | | 37 | | | | | | 6,917 | | |
LOSS BEFORE INCOME TAXES
|
| | | | (341,986) | | | | | | (825,935) | | |
INCOME TAX BENEFIT
|
| | | | (20,347) | | | | | | (238,929) | | |
NET LOSS
|
| | | $ | (321,639) | | | | | $ | (587,006) | | |
LOSS PER COMMON SHARE | | | | | | | | | | | | | |
Basic
|
| | | $ | (0.16) | | | | | $ | (0.30) | | |
Diluted
|
| | | $ | (0.16) | | | | | $ | (0.30) | | |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | | | | | | | | | | | | | |
Basic
|
| | | | 1,976,771 | | | | | | 1,976,354 | | |
Diluted
|
| | | | 1,976,771 | | | | | | 1,976,354 | | |
| | |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Retained
Earnings |
| |
Total
Stock- holders’ Equity |
| ||||||||||||||||||
|
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||
BALANCE AT DECEMBER
31, 2020 |
| | | | 1,976,354 | | | | | $ | 197,635 | | | | | $ | 2,743,930 | | | | | $ | 8,897,781 | | | | | $ | 11,839,346 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (321,639) | | | | | | (321,639) | | |
Exercise of stock options and net of related tax benefit
|
| | | | 750 | | | | | | 75 | | | | | | 6,316 | | | | | | — | | | | | | 6,391 | | |
Stock based compensation
|
| | | | — | | | | | | — | | | | | | 37,487 | | | | | | — | | | | | | 37,487 | | |
BALANCE AT MARCH 31, 2021
|
| | | | 1,977,104 | | | | | $ | 197,710 | | | | | $ | 2,787,733 | | | | | $ | 8,576,142 | | | | | $ | 11,561,585 | | |
| | |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Retained
Earnings |
| |
Total
Stock- holders’ Equity |
| ||||||||||||||||||
|
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||
BALANCE AT DECEMBER
31, 2019 |
| | | | 1,976,354 | | | | | $ | 197,635 | | | | | $ | 2,721,962 | | | | | $ | 9,337,101 | | | | | $ | 12,256,698 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (587,006) | | | | | | (587,006) | | |
Stock based compensation
|
| | | | — | | | | | | — | | | | | | 3,688 | | | | | | — | | | | | | 3,688 | | |
BALANCE AT MARCH 31, 2020
|
| | | | 1,976,354 | | | | | $ | 197,635 | | | | | $ | 2,725,650 | | | | | $ | 8,750,095 | | | | | $ | 11,673,380 | | |
| | |
Three Months Ended
March 31, |
| |||||||||
|
2021
|
| |
2020
|
| ||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (321,639) | | | | | $ | (587,006) | | |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
| | | | | | | | | | | | |
Depreciation
|
| | | | 160,561 | | | | | | 167,623 | | |
Amortization
|
| | | | 9,000 | | | | | | 9,454 | | |
Stock based compensation
|
| | | | 37,487 | | | | | | 3,688 | | |
Net gain on sale and disposal of equipment
|
| | | | — | | | | | | (2,324) | | |
Changes in working capital components:
|
| | | | | | | | | | | | |
Trade receivables
|
| | | | 573,686 | | | | | | 674,552 | | |
Inventories
|
| | | | (316,941) | | | | | | (408,233) | | |
Prepaid expenses and other assets
|
| | | | (84,926) | | | | | | 578,479 | | |
Income tax receivable
|
| | | | 201,409 | | | | | | (244,254) | | |
Accounts payable
|
| | | | 412,843 | | | | | | 1,575 | | |
Accrued expenses
|
| | | | 99,875 | | | | | | (620,830) | | |
Net cash provided by (used in) operating activities
|
| | | | 771,355 | | | | | | (427,276) | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | | | |
Purchases of property and equipment
|
| | | | — | | | | | | (135,125) | | |
Proceeds from sales of equipment
|
| | | | — | | | | | | 18,297 | | |
Purchases of intangible assets
|
| | | | (6,787) | | | | | | (3,423) | | |
Proceeds on sale of short-term investments
|
| | | | — | | | | | | 1,225,000 | | |
Net cash (used in) provided by investing activities
|
| | | | (6,787) | | | | | | 1,104,749 | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | | | |
Payment on long-term debt
|
| | | | (36,826) | | | | | | (35,682) | | |
Proceeds from exercise of stock options
|
| | | | 6,682 | | | | | | — | | |
Net cash used in financing activities
|
| | | | (30,144) | | | | | | (35,682) | | |
NET INCREASE IN CASH
|
| | | | 734,424 | | | | | | 641,791 | | |
CASH AT BEGINNING OF PERIOD
|
| | | | 3,693,845 | | | | | | 963,649 | | |
CASH AT END OF PERIOD
|
| | | $ | 4,428,269 | | | | | $ | 1,605,440 | | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 17,960 | | | | | $ | 19,105 | | |
Cash received (paid for) income taxes, net
|
| | | $ | 221,756 | | | | | $ | (5,325) | | |
| | |
Mar 31, 2021
|
| |
Dec 31, 2020
|
| ||||||
Raw materials
|
| | | $ | 1,339,843 | | | | | $ | 1,323,655 | | |
Work-in-progress
|
| | | | 448,424 | | | | | | 428,753 | | |
Finished goods
|
| | | | 1,357,647 | | | | | | 1,065,458 | | |
Reduction to LIFO cost
|
| | | | (1,183,998) | | | | | | (1,172,891) | | |
Total Inventories
|
| | | $ | 1,961,916 | | | | | $ | 1,644,975 | | |
| | |
Three Months Ended
|
| |||||||||
| | |
Mar 31, 2021
|
| |
Mar 31, 2020
|
| ||||||
Weighted average common shares outstanding
|
| | | | 1,976,771 | | | | | | 1,976,354 | | |
Dilutive effect of stock options and restricted stock units
|
| | | | — | | | | | | — | | |
Weighted average common and common equivalent shares outstanding
|
| | | | 1,976,771 | | | | | | 1,976,354 | | |
| | |
2021
|
| |
2020
|
| ||||||
Dividend yield
|
| | | | — | | | | | | — | | |
Expected volatility
|
| | | | 51.6% | | | | | | 40.3% | | |
Expected life of option (years)
|
| | | | 10 | | | | | | 10 | | |
Risk-free interest rate
|
| | | | 1.4% | | | | | | 1.4% | | |
Fair value of each option on grant date
|
| | | $ | 7.05 | | | | | $ | 2.90 | | |
| | |
Shares
|
| |
Weighted
Average Exercise Price |
| ||||||
Outstanding at January 1, 2021
|
| | | | 17,500 | | | | | $ | 6.97 | | |
Granted
|
| | | | 10,000 | | | | | | 11.50 | | |
Exercised
|
| | | | (750) | | | | | | 8.91 | | |
Expired and forfeited
|
| | | | — | | | | | | — | | |
Outstanding at March 31, 2021
|
| | | | 26,750 | | | | | $ | 8.61 | | |
Exercisable at March 31, 2021
|
| | | | 7,915 | | | | | $ | 7.73 | | |
| | |
Number of
Shares |
| |
Weighted
Average Grant Date Fair Value |
| ||||||
Unvested shares at January 1, 2021
|
| | | | 54,300 | | | | | $ | 6.11 | | |
Granted
|
| | | | 1,500 | | | | | | 9.85 | | |
Vested
|
| | | | — | | | | | | — | | |
Forfeited or surrendered
|
| | | | — | | | | | | — | | |
Unvested shares at March 31, 2021
|
| | | | 55,800 | | | | | | 6.21 | | |
| | |
IKONICS
|
| |||||||||||||||||||||||||||||||||
| | | | | | | | |
IKONICS
|
| | | | | | | | | | | | | | | | | | | | | | | | | |||
| | |
Chromaline
|
| |
Imaging
|
| |
DTX
|
| |
AMS
|
| |
Unalloc.
|
| |
Total
|
| ||||||||||||||||||
Net sales
|
| | | $ | 1,698,681 | | | | | $ | 1,086,601 | | | | | $ | 76,311 | | | | | $ | 211,815 | | | | | $ | — | | | | | $ | 3,073,408 | | |
Cost of goods sold
|
| | | | 1,234,785 | | | | | | 549,655 | | | | | | 42,792 | | | | | | 249,844 | | | | | | — | | | | | | 2,077,076 | | |
Gross profit (loss)
|
| | | | 463,896 | | | | | | 536,946 | | | | | | 33,519 | | | | | | (38,029) | | | | | | — | | | | | | 996,332 | | |
Selling general and administrative*
|
| | | | 258,002 | | | | | | 216,536 | | | | | | 30,039 | | | | | | 58,621 | | | | | | 620,393 | | | | | | 1,183,591 | | |
Research and development*
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 134,922 | | | | | | 134,922 | | |
Income (loss) from operations
|
| | | $ | 205,894 | | | | | $ | 320,410 | | | | | $ | 3,480 | | | | | $ | (96,650) | | | | | $ | (755,315) | | | | | $ | (322,181) | | |
| | |
IKONICS
|
| |||||||||||||||||||||||||||||||||
| | | | | | | | |
IKONICS
|
| | | | | | | | | | | | | | | | | | | | | | | | | |||
| | |
Chromaline
|
| |
Imaging
|
| |
DTX
|
| |
AMS
|
| |
Unalloc.
|
| |
Total
|
| ||||||||||||||||||
Net sales
|
| | | $ | 1,964,340 | | | | | $ | 970,099 | | | | | $ | 112,529 | | | | | $ | 450,224 | | | | | $ | — | | | | | $ | 3,497,192 | | |
Cost of goods sold
|
| | | | 1,418,269 | | | | | | 477,723 | | | | | | 51,746 | | | | | | 396,222 | | | | | | — | | | | | | 2,343,960 | | |
Gross profit
|
| | | | 546,071 | | | | | | 492,376 | | | | | | 60,783 | | | | | | 54,002 | | | | | | — | | | | | | 1,153,232 | | |
Selling general and administrative*
|
| | | | 426,219 | | | | | | 278,862 | | | | | | 34,373 | | | | | | 103,109 | | | | | | 938,457 | | | | | | 1,781,020 | | |
Research and development*
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 183,580 | | | | | | 183,580 | | |
Income (loss) from operations
|
| | | $ | 119,852 | | | | | $ | 213,514 | | | | | $ | 26,410 | | | | | $ | (49,107) | | | | | $ | (1,122,037) | | | | | $ | (811,368) | | |
| | |
Mar 31, 2021
|
| |
Dec 31, 2020
|
| ||||||
Chromaline
|
| | | $ | 1,106,648 | | | | | $ | 1,676,592 | | |
IKONICS Imaging
|
| | | | 247,725 | | | | | | 396,116 | | |
DTX
|
| | | | 33,388 | | | | | | 35,983 | | |
AMS
|
| | | | 181,975 | | | | | | 57,676 | | |
Unallocated
|
| | | | (24,209) | | | | | | (47,154) | | |
Total
|
| | | $ | 1,545,527 | | | | | $ | 2,119,213 | | |
| | |
December 31,
2020 |
| |
December 31,
2019 |
| ||||||
ASSETS | | | | | | | | | | | | | |
CURRENT ASSETS: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 3,693,845 | | | | | $ | 963,649 | | |
Short-term investments
|
| | | | — | | | | | | 2,205,000 | | |
Trade receivables, less allowance of $55,000 in 2020 and $58,000 in 2019
|
| | | | 2,119,213 | | | | | | 2,434,718 | | |
Inventories, net
|
| | | | 1,644,975 | | | | | | 2,180,536 | | |
Prepaid expenses and other assets
|
| | | | 125,969 | | | | | | 906,916 | | |
Income taxes receivable
|
| | | | 219,451 | | | | | | 1,369 | | |
Total current assets
|
| | | | 7,803,453 | | | | | | 8,692,188 | | |
PROPERTY, PLANT, AND EQUIPMENT, at cost: | | | | | | | | | | | | | |
Land and building
|
| | | | 9,556,586 | | | | | | 9,556,984 | | |
Machinery and equipment
|
| | | | 5,263,586 | | | | | | 5,198,784 | | |
Office equipment
|
| | | | 1,417,219 | | | | | | 1,402,369 | | |
Vehicles
|
| | | | 245,674 | | | | | | 245,674 | | |
| | | | | 16,483,065 | | | | | | 16,403,811 | | |
Less accumulated depreciation
|
| | | | (9,094,702) | | | | | | (8,487,827) | | |
Total property, plant and equipment at cost, net
|
| | | | 7,388,363 | | | | | | 7,915,984 | | |
PATENTS, less accumulated amortization of $207,399 in 2020 and $181,609 in 2019
|
| | | | 243,583 | | | | | | 271,369 | | |
Total assets
|
| | | $ | 15,435,399 | | | | | $ | 16,879,541 | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | |
CURRENT LIABILITIES | | | | | | | | | | | | | |
Current portion of long-term debt
|
| | | $ | 2,688,396 | | | | | $ | 133,287 | | |
Accounts payable
|
| | | | 459,836 | | | | | | 761,641 | | |
Accrued compensation
|
| | | | 279,755 | | | | | | 382,303 | | |
Other accrued liabilities
|
| | | | 168,066 | | | | | | 657,255 | | |
Total current liabilities
|
| | | | 3,596,053 | | | | | | 1,934,486 | | |
LONG-TERM LIABILITIES | | | | | | | | | | | | | |
Long-term debt, less current portion
|
| | | | — | | | | | | 2,688,357 | | |
Total liabilities
|
| | | | 3,596,053 | | | | | | 4,622,843 | | |
COMMITMENTS AND CONTINGENCIES | | | | | | | | | | | | | |
STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | |
Preferred stock, par value $.10 per share; authorized 250,000 shares; issued none
|
| | | | — | | | | | | — | | |
Common stock, par value $.10 per share; authorized 4,750,000 shares; issued and outstanding 1,976,354 shares in 2020 and 2019
|
| | | | 197,635 | | | | | | 197,635 | | |
Additional paid-in-capital
|
| | | | 2,743,930 | | | | | | 2,721,962 | | |
Retained earnings
|
| | | | 8,897,781 | | | | | | 9,337,101 | | |
Total stockholders’ equity
|
| | | | 11,839,346 | | | | | | 12,256,698 | | |
Total liabilities and stockholders’ equity
|
| | | $ | 15,435,399 | | | | | $ | 16,879,541 | | |
| | |
Year Ended
December 31, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
NET SALES
|
| | | $ | 13,432,220 | | | | | $ | 17,618,559 | | |
COST OF GOODS SOLD
|
| | | | 9,527,143 | | | | | | 12,221,370 | | |
GROSS PROFIT
|
| | | | 3,905,077 | | | | | | 5,397,189 | | |
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
|
| | | | 5,019,604 | | | | | | 5,483,586 | | |
RESEARCH AND DEVELOPMENT EXPENSES
|
| | | | 671,493 | | | | | | 870,279 | | |
LOSS FROM OPERATIONS
|
| | | | (1,786,020) | | | | | | (956,676) | | |
INTEREST EXPENSE
|
| | | | (86,561) | | | | | | (90,058) | | |
OTHER INCOME
|
| | | | 1,223,261 | | | | | | 61,176 | | |
LOSS BEFORE INCOME TAXES
|
| | | | (649,320) | | | | | | (985,558) | | |
INCOME TAX BENEFIT
|
| | | | (210,000) | | | | | | (172,000) | | |
NET LOSS
|
| | | $ | (439,320) | | | | | $ | (813,558) | | |
LOSS PER COMMON SHARE | | | | | | | | | | | | | |
Basic
|
| | | $ | (0.22) | | | | | $ | (0.41) | | |
Diluted
|
| | | $ | (0.22) | | | | | $ | (0.41) | | |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING | | | | | | | | | | | | | |
Basic
|
| | | | 1,976,354 | | | | | | 1,980,253 | | |
Diluted
|
| | | | 1,976,354 | | | | | | 1,980,253 | | |
| | |
Common Stock
|
| |
Additional
Paid-in Capital |
| |
Retained
Earnings |
| |
Total
Stock- holders’ Equity |
| ||||||||||||||||||
|
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||
BALANCE AT DECEMBER 31, 2018
|
| | | | 1,983,553 | | | | | $ | 198,355 | | | | | $ | 2,723,024 | | | | | $ | 10,189,651 | | | | | $ | 13,111,030 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (813,558) | | | | | | (813,558) | | |
Common stock repurchased
|
| | | | (7,199) | | | | | | (720) | | | | | | (9,883) | | | | | | (38,992) | | | | | | (49,595) | | |
Stock based compensation
|
| | | | — | | | | | | — | | | | | | 8,821 | | | | | | — | | | | | | 8,821 | | |
BALANCE AT DECEMBER 31, 2019
|
| | | | 1,976,354 | | | | | | 197,635 | | | | | | 2,721,962 | | | | | | 9,337,101 | | | | | | 12,256,698 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | (439,320) | | | | | | (439,320) | | |
Stock based compensation
|
| | | | — | | | | | | — | | | | | | 21,968 | | | | | | — | | | | | | 21,968 | | |
BALANCE AT DECEMBER 31, 2020
|
| | | | 1,976,354 | | | | | $ | 197,635 | | | | | $ | 2,743,930 | | | | | $ | 8,897,781 | | | | | $ | 11,839,346 | | |
| | |
Year Ended
December 31, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (439,320) | | | | | $ | (813,558) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Depreciation
|
| | | | 661,565 | | | | | | 639,997 | | |
Amortization
|
| | | | 36,489 | | | | | | 43,014 | | |
Stock based compensation
|
| | | | 21,968 | | | | | | 8,821 | | |
Forgiveness on paycheck protection loan
|
| | | | (1,214,500) | | | | | | — | | |
Net gain on sale and disposal of equipment
|
| | | | (2,325) | | | | | | (8,482) | | |
Deferred income taxes
|
| | | | — | | | | | | (183,000) | | |
Abandonment of patents
|
| | | | 16,906 | | | | | | 92,833 | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Trade receivables
|
| | | | 315,505 | | | | | | (219,503) | | |
Inventories
|
| | | | 535,561 | | | | | | (133,948) | | |
Prepaid expenses and other assets
|
| | | | 780,947 | | | | | | (531,554) | | |
Income tax receivable
|
| | | | (218,082) | | | | | | 1,399 | | |
Accounts payable
|
| | | | (301,805) | | | | | | 114,113 | | |
Accrued expenses
|
| | | | (591,737) | | | | | | 512,837 | | |
Net cash used in operating activities
|
| | | | (398,828) | | | | | | (477,031) | | |
CASH FLOWS FROM INVESTING ACTIVITIES: | | | | | | | | | | | | | |
Purchases of property and equipment
|
| | | | (149,916) | | | | | | (478,353) | | |
Proceeds from sales of equipment
|
| | | | 18,297 | | | | | | 15,596 | | |
Purchases of patents
|
| | | | (14,910) | | | | | | (19,665) | | |
Purchases of short-term investments
|
| | | | — | | | | | | (5,635,000) | | |
Proceeds on sale of short-term investments
|
| | | | 2,205,000 | | | | | | 6,125,000 | | |
Net cash provided by investing activities
|
| | | | 2,058,471 | | | | | | 7,578 | | |
CASH FLOWS FROM FINANCING ACTIVITIES: | | | | | | | | | | | | | |
Proceeds from paycheck protection program loan
|
| | | | 1,214,500 | | | | | | — | | |
Principal payments on long-term debt
|
| | | | (143,947) | | | | | | (140,440) | | |
Repurchase of common stock
|
| | | | — | | | | | | (49,595) | | |
Net cash provided by (used in) financing activities
|
| | | | 1,070,553 | | | | | | (190,035) | | |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
| | | | 2,730,196 | | | | | | (659,488) | | |
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
|
| | | | 963,649 | | | | | | 1,623,137 | | |
CASH AND CASH EQUIVALENTS AT END OF YEAR
|
| | | $ | 3,693,845 | | | | | $ | 963,649 | | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 75,227 | | | | | $ | 79,008 | | |
Cash paid for income taxes, net
|
| | | $ | 8,082 | | | | | $ | 9,457 | | |
| | |
Dec 31, 2020
|
| |
Dec 31, 2019
|
| ||||||
Raw materials
|
| | | $ | 1,323,655 | | | | | $ | 1,667,154 | | |
Work-in-progress
|
| | | | 428,753 | | | | | | 419,906 | | |
Finished goods
|
| | | | 1,065,458 | | | | | | 1,449,854 | | |
Reduction to LIFO cost
|
| | | | (1,172,891) | | | | | | (1,356,378) | | |
Total Inventories
|
| | | $ | 1,644,975 | | | | | $ | 2,180,536 | | |
| | |
Years
|
|
Buildings
|
| |
15 – 40
|
|
Machinery and equipment
|
| |
5 – 10
|
|
Office equipment
|
| |
3 – 10
|
|
Vehicles
|
| |
3
|
|
| | |
Dec 31, 2020
|
| |
Dec 31, 2019
|
| ||||||
Weighted average common shares outstanding
|
| | | | 1,976,354 | | | | | | 1,980,253 | | |
Dilutive effect of stock options and restricted stock units
|
| | | | — | | | | | | — | | |
Weighted average common and common equivalent shares outstanding
|
| | | | 1,976,354 | | | | | | 1,980,253 | | |
| | |
2020
|
| |
2019
|
| ||||||
Current: | | | | | | | | | | | | | |
Federal
|
| | | $ | (216,000) | | | | | $ | — | | |
State
|
| | | | 6,000 | | | | | | 11,000 | | |
| | | | | (210,000) | | | | | | 11,000 | | |
Deferred — Federal
|
| | | | — | | | | | | (183,000) | | |
| | | | $ | (210,000) | | | | | $ | (172,000) | | |
| | |
2020
|
| |
2019
|
| ||||||
Expected provision for federal income taxes
|
| | | $ | (136,000) | | | | | $ | (207,000) | | |
State income taxes, net of federal benefit
|
| | | | (24,000) | | | | | | (7,000) | | |
Permanent items
|
| | | | (249,000) | | | | | | 11,000 | | |
Research and development credit
|
| | | | (23,000) | | | | | | (29,000) | | |
Change in valuation allowance
|
| | | | 440,000 | | | | | | 51,000 | | |
Change in tax law allowing NOL carryback claim
|
| | | | (217,000) | | | | | | — | | |
Prior year true-ups and other
|
| | | | (1,000) | | | | | | 9,000 | | |
| | | | $ | (210,000) | | | | | $ | (172,000) | | |
| | |
2020
|
| |
2019
|
| ||||||
Deferred tax liabilities: | | | | | | | | | | | | | |
Accrued vacation
|
| | | $ | 33,000 | | | | | $ | 21,000 | | |
Inventories reserve
|
| | | | 17,000 | | | | | | 42,000 | | |
Allowance for doubtful accounts
|
| | | | 2,000 | | | | | | 3,000 | | |
Allowance for sales returns
|
| | | | 10,000 | | | | | | 10,000 | | |
Research and development credit carryforward
|
| | | | 285,000 | | | | | | 245,000 | | |
Accrued self-insured medical
|
| | | | — | | | | | | 3,000 | | |
Property and equipment
|
| | | | (257,000) | | | | | | (295,000) | | |
Patents
|
| | | | (50,000) | | | | | | (53,000) | | |
Net operating loss
|
| | | | 411,000 | | | | | | 230,000 | | |
Other
|
| | | | 17,000 | | | | | | 8,000 | | |
Valuation allowance
|
| | | | (468,000) | | | | | | (214,000) | | |
Net deferred tax liabilities
|
| | | $ | — | | | | | $ | — | | |
| | |
December 31, 2020
|
| |
December 31, 2019
|
| ||||||||||||||||||
|
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| |
Gross
Carrying Amount |
| |
Accumulated
Amortization |
| ||||||||||||||
Amortized intangible assets: | | | | | | | | | | | | | | | | | | | | | | | | | |
Patents
|
| | | $ | 450,982 | | | | | $ | (207,399) | | | | | $ | 452,978 | | | | | $ | (181,609) | | |
| | |
2020
|
| |
2019
|
| ||||||
Aggregate amortization expense:
|
| | | | | | | | | | | | |
For the years ended December 31
|
| | | $ | 25,790 | | | | | $ | 31,869 | | |
|
2021
|
| | | $ | 25,000 | | |
|
2022
|
| | | | 25,000 | | |
|
2023
|
| | | | 25,000 | | |
|
2024
|
| | | | 24,000 | | |
|
2025
|
| | | | 24,000 | | |
|
Thereafter
|
| | | | 67,000 | | |
| | |
Chromaline
|
| |
IKONICS
Imaging |
| |
DTX
|
| |
AMS
|
| |
Unalloc.
|
| |
Total
|
| ||||||||||||||||||
Net sales
|
| | | $ | 8,475,743 | | | | | $ | 3,709,318 | | | | | $ | 294,929 | | | | | $ | 952,230 | | | | | $ | — | | | | | $ | 13,432,220 | | |
Cost of goods sold
|
| | | | 6,222,902 | | | | | | 1,972,076 | | | | | | 140,866 | | | | | | 1,191,299 | | | | | | — | | | | | | 9,527,143 | | |
Gross profit (loss)
|
| | | | 2,252,841 | | | | | | 1,737,242 | | | | | | 154,063 | | | | | | (239,069) | | | | | | — | | | | | | 3,905,077 | | |
Selling, general, and administrative*
|
| | | | 1,297,045 | | | | | | 880,404 | | | | | | 125,752 | | | | | | 275,147 | | | | | | 2,441,256 | | | | | | 5,019,604 | | |
Research and development*
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 671,493 | | | | | | 671,493 | | |
Income (loss) from operations
|
| | | $ | 955,796 | | | | | $ | 856,838 | | | | | $ | 28,311 | | | | | $ | (514,216) | | | | | $ | (3,112,749) | | | | | $ | (1,786,020) | | |
| | |
Chromaline
|
| |
IKONICS
Imaging |
| |
DTX
|
| |
AMS
|
| |
Unalloc.
|
| |
Total
|
| ||||||||||||||||||
Net sales
|
| | | $ | 11,472,111 | | | | | $ | 4,191,175 | | | | | $ | 393,804 | | | | | $ | 1,561,469 | | | | | $ | — | | | | | $ | 17,618,559 | | |
Cost of goods sold
|
| | | | 8,389,404 | | | | | | 2,273,641 | | | | | | 157,650 | | | | | | 1,400,675 | | | | | | — | | | | | | 12,221,370 | | |
Gross profit
|
| | | | 3,082,707 | | | | | | 1,917,534 | | | | | | 236,154 | | | | | | 160,794 | | | | | | — | | | | | | 5,397,189 | | |
Selling, general, and administrative*
|
| | | | 1,832,473 | | | | | | 1,081,847 | | | | | | 149,924 | | | | | | 361,342 | | | | | | 2,058,000 | | | | | | 5,483,586 | | |
Research and development*
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 870,279 | | | | | | 870,279 | | |
Income (loss) from operations
|
| | | $ | 1,250,234 | | | | | $ | 835,687 | | | | | $ | 86,230 | | | | | $ | (200,548) | | | | | $ | (2,928,279) | | | | | $ | (956,676) | | |
| | |
Dec 31, 2020
|
| |
Dec 31, 2019
|
| ||||||
Chromaline
|
| | | $ | 1,676,592 | | | | | $ | 1,916,066 | | |
IKONICS Imaging
|
| | | | 396,116 | | | | | | 304,791 | | |
DTX
|
| | | | 35,983 | | | | | | 13,919 | | |
AMS
|
| | | | 57,676 | | | | | | 252,363 | | |
Unallocated
|
| | | | (47,154) | | | | | | (52,421) | | |
Total
|
| | | $ | 2,119,213 | | | | | $ | 2,434,718 | | |
| | |
2020
|
| |
2019
|
|
Dividend yield
|
| |
0
|
| |
0
|
|
Expected volatility
|
| |
40.3%
|
| |
37.5%
|
|
Expected life of option (years)
|
| |
10
|
| |
5
|
|
Risk-free interest rate
|
| |
1.4%
|
| |
1.7%
|
|
Fair value of each option on grant date
|
| |
$2.90
|
| |
$2.53
|
|
| | |
Shares
|
| |
Weighted
Average Exercise Price |
| ||||||
Outstanding at January 1, 2020
|
| | | | 19,250 | | | | | $ | 11.32 | | |
Granted
|
| | | | 10,000 | | | | | | 5.67 | | |
Exercised
|
| | | | — | | | | | | — | | |
Expired and forfeited
|
| | | | (11,750) | | | | | | 12.99 | | |
Outstanding at December 31, 2020
|
| | | | 17,500 | | | | | $ | 6.97 | | |
Exercisable at December 31, 2020
|
| | | | 5,332 | | | | | $ | 9.19 | | |
| | |
Number of
Shares |
| |
Weighted
Average Grant Date Fair Value |
| ||||||
Unvested shares at January 1, 2020
|
| | | | — | | | | | | — | | |
Granted
|
| | | | 54,300 | | | | | $ | 6.11 | | |
Vested
|
| | | | — | | | | | | — | | |
Forfeited or surrendered
|
| | | | — | | | | | | — | | |
Unvested shares at December 31, 2020
|
| | | | 54,300 | | | | | | 6.11 | | |
|
2021
|
| | | | 2,773,000 | | |
|
Less: Unamortized debt issuance costs
|
| | | | 85,000 | | |
|
Less: Current portion
|
| | | | 2,688,000 | | |
|
Long-term portion
|
| | | $ | — | | |
|
Exhibit
|
| |
Description of Exhibit
|
|
| 10.8 | | | | |
| 10.9 | | | | |
| 23.1 | | | | |
| 23.2 | | | | |
| 23.3† | | | Consent of Faegre Drinker Biddle & Reath LLP (included in Exhibit 5.1 and Exhibit 8.1) | |
| 99.1 | | | | |
| 99.2† | | | Form of Proxy Card for Special Meeting of IKONICS Corporation | |
| 99.3† | | | Consents of Persons About to Become a Director | |
| 101† | | | Interactive data files pursuant to Rule 405 of Regulation S-T | |
| | | |
TELLURIDE HOLDCO, INC.
|
| |||
| | | | By: | | |
/s/ Glenn Sandgren
Glenn Sandgren
Chief Executive Officer |
|
|
Signature
|
| |
Title
|
|
|
/s/ Glenn Sandgren
Glenn Sandgren
|
| |
Chief Executive Officer, Director
(principal executive officer) |
|
|
/s/ Jon Gerlach
Jon Gerlach
|
| |
Chief Financial Officer, Director
(principal financial and accounting officer) |
|